NIVALIS THERAPEUTICS INC Chart calendar Nivalis Therapeutics Inc
7ca84bef5f.KTYx1mc6Kcdd5UEKL-o_e3ms27nSMRkIQDaLBkOZvq4.U0VFrhMCfJUeknBYdb94MTj_qvzmV21wKw_yMAzKyf5FYQeALHFArCrRIg~49c7ea6ea82a6a7c16a25663533337b4
Upcoming events on Nivalis Therapeutics Inc
Past events on Nivalis Therapeutics Inc
| 14/05/2024 | RBC Capital Markets Global Healthcare Conference |
| 10/05/2024 01:30 am | Q1 2024 Earnings Release |
| 16/04/2024 02:15 am | World Congress of Nephrology Meeting |
| 11/04/2024 02:45 am | Acquisition of Alpine Immune Sciences Inc by Vertex Pharmaceuticals Incorporated Call |
| 29/03/2024 12:30 am | H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference |
| 21/03/2024 | SLEuro European Lupus Meeting - Poster No:P104 |
| 19/03/2024 02:00 am | Q4 2023 Earnings Call |
| 19/03/2024 01:35 am | Q4 2023 Earnings Release |
| 12/03/2024 11:50 pm | Leerink Partners Global Biopharma Conference |
| 04/03/2024 07:40 pm | TD Cowen Health Care Conference |
| 14/02/2024 10:30 pm | Oppenheimer Healthcare Life Sciences Conference - Fireside Chat |
| 08/02/2024 08:30 pm | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
| 10/01/2024 09:00 pm | JPMorgan Healthcare Conference |
| 30/11/2023 06:25 pm | Evercore ISI HealthconX Conference |
| 15/11/2023 02:45 am | Q3 2023 Earnings Release |
| 14/11/2023 10:30 pm | American College of Rheumatology Conference - Abstract No 1553950 |
| 12/11/2023 10:30 pm | American College of Rheumatology Conference - Abstract No 1553700 |
| 04/11/2023 03:30 am | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting |
| 03/11/2023 06:30 am | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting |
| 03/11/2023 02:00 am | Investor Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,74 0,99 75.14% | 9,34 6,28 48.6% | 23,4 32,9 -28.7% | 30,1 38,3 -21.41% | 58,9 35,7 64.85% | 17,7 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -49,2 -51,5 4.39% | -58,3 -85,7 32% | -43,7 -64,2 31.93% | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -43,6 -49,0 10.99% | -28,7 -29,7 3.26% | -49,9 -43,2 -15.52% | -58,1 -56,9 -2.19% | -44,3 -63,4 30.24% | -103 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -41,9 -48,2 13.12% | -27,9 -29,6 5.7% | -50,4 -49,3 -2.24% | -55,4 -49,0 -13.05% | -32,1 -54,1 40.75% | -96,5 |
|
Net income Million USD | Released Forecast Spread | -41,9 -48,2 13.12% | -27,9 -29,2 4.35% | -50,3 -43,8 -14.83% | -57,8 -51,1 -13.1% | -32,2 -54,8 41.28% | -97,3 |
|
EPS USD | Released Forecast Spread | -2,28 -2,54 10.24% | -1,34 -1,44 6.82% | -1,98 -1,73 -14.45% | -1,73 -1,59 -8.94% | -0,64 -1,07 40.03% | -1,35 |
| Announcement Date | 30/03/20 | 18/03/21 | 17/03/22 | 23/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13,6 16,3 -16.2% | 5,29 10,0 -47.31% | 8,37 18,7 -55.22% | 2,78 11,0 -74.68% | 9,39 6,88 36.44% | 8,59 7,08 21.37% | 10,0 7,25 38.54% | 30,9 9,10 238.89% | 7,03 3,52 100% | 3,59 | 3,60 | 5,67 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -7,31 -14,9 50.95% | -16,3 -17,7 7.72% | -13,7 17,4 -178.64% | -15,5 -16,8 8.02% | -15,5 -17,9 13.34% | -14,4 -17,4 17.22% | 1,70 -15,2 111.15% | -22,5 -30,3 25.58% | ||||||
|
EBIT Million USD | Released Forecast Spread | -7,46 -2,53 -195.01% | -16,5 -10,1 -63.84% | -13,8 -10,8 -28.24% | -20,4 -11,5 -77.27% | -15,6 -17,8 12.35% | -15,7 -19,1 17.83% | -14,6 -17,8 18.17% | 1,55 -15,5 109.99% | -22,7 -24,9 9.01% | -26,9 | -29,2 | -28,2 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,52 -8,58 12.3% | -16,3 -13,6 -19.56% | -13,3 -12,1 -9.82% | -18,3 -11,9 -54.08% | -13,3 -17,5 24.25% | -13,2 -17,7 25.81% | -11,7 -16,5 29% | 6,06 -15,2 139.77% | -17,9 -24,3 26.38% | -25,2 | -27,5 | -22,4 | ||
|
Net income Million USD | Released Forecast Spread | -7,53 -5,60 -34.39% | -18,1 -12,0 -51.26% | -13,3 -10,8 -23.4% | -18,9 -12,2 -54.69% | -13,3 -17,2 22.74% | -13,2 -17,8 25.95% | -11,7 -16,2 27.46% | 5,96 -16,2 136.89% | -17,9 -24,0 25.19% | -24,9 | -27,0 | -24,0 | ||
|
EPS USD | Released Forecast Spread | -0,25 -0,19 -33.33% | -0,60 -0,39 -52.87% | -0,42 -0,32 -29.9% | -0,41 -0,27 -52.99% | -0,28 -0,37 24.32% | -0,27 -0,37 26.23% | -0,24 -0,33 26.9% | 0,15 -0,30 150.85% | -0,28 -0,40 29.71% | -0,37 | -0,38 | -0,38 | ||
| Announcement Date | 12/05/22 | 11/08/22 | 14/11/22 | 23/03/23 | 11/05/23 | 14/08/23 | 14/11/23 | 18/03/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for Nivalis Therapeutics Inc
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 05:30 pm | IMMUNOME, INC.: Q1 2024 Earnings Release |
